Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity.
about
The 5-HT3 receptor as a therapeutic targetSerotonin 5-HT3 receptor-mediated vomiting occurs via the activation of Ca2+/CaMKII-dependent ERK1/2 signaling in the least shrew (Cryptotis parva)Chemotherapy agent cisplatin induces 48-h Fos expression in the brain of a vomiting species, the house musk shrew (Suncus murinus).Pranlukast prevents cysteinyl leukotriene-induced emesis in the least shrew (Cryptotis parva).Rotavirus stimulates release of serotonin (5-HT) from human enterochromaffin cells and activates brain structures involved in nausea and vomitingAssociation of ABCB1, 5-HT3B receptor and CYP2D6 genetic polymorphisms with ondansetron and metoclopramide antiemetic response in Indonesian cancer patients treated with highly emetogenic chemotherapy.5-Hydroxytryptamine (5-HT) cellular sequestration during chronic exposure delays 5-HT3 receptor resensitization due to its subsequent release.The relationship between perioperative nausea and vomiting and serum serotonin concentrations in patients undergoing cesarean section under epidural anesthesia.Plasma pharmacokinetics and tissue and brain distribution of cisplatin in musk shrewsThe expanded biology of serotonin.Assessment of low-dose cisplatin as a model of nausea and emesis in beagle dogs, potential for repeated administration.Anti-emetic mechanisms of Zingiber officinale against cisplatin induced emesis in the pigeon; behavioral and neurochemical correlatesFFA2 activation combined with ulcerogenic COX inhibition induces duodenal mucosal injury via the 5-HT pathway in rats.Drugs acting on serotonin receptors for the treatment of functional GI disorders.The pyrrole etomidate analog carboetomidate potently inhibits human 5-HT3A receptor function: comparisons with etomidate and potential implications for emetogenesis5-HT₃ receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cellsReceptor-selective agonists induce emesis and Fos expression in the brain and enteric nervous system of the least shrew (Cryptotis parva).Pathophysiological and neurochemical mechanisms of postoperative nausea and vomitingCisplatin : an old drug with a newfound efficacy -- from mechanisms of action to cytotoxicity.Palonosetron for the prevention of chemotherapy-induced nausea and vomiting.GSTP1 c.313A>G, XPD c.934G>A, XPF c.2505T>C and CASP9 c.-1339A>G Polymorphisms and Severity of Vomiting in Head and Neck Cancer Patients treated with Cisplatin Chemoradiation.Ginger augmented chemotherapy: A novel multitarget nontoxic approach for cancer management.Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting.Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment.Profile of Antiemetic Activity of Netupitant Alone or in Combination with Palonosetron and Dexamethasone in Ferrets and Suncus murinus (House Musk Shrew).Mechanism of gastrointestinal abnormal motor activity induced by cisplatin in conscious dogsProlonged inhibition of 5-HT₃ receptors by palonosetron results from surface receptor inhibition rather than inducing receptor internalization.Psychiatric Co-morbidity and Efficacy of Mirtazapine Treatment in Young Subjects With Chronic or Cyclic Vomiting Syndromes: A Case Series.Mirtazapine for depression and comorbidities in older patients with cancer.Chemotherapy-Induced Pica in Rats Reduced by Electroacupuncture.5-Hydroxytryptamine effects in the gut: the 3, 4, and 7 receptors.Chemotherapy-induced pica and anorexia are reduced by common hepatic branch vagotomy in the rat.Luminal hypotonicity increases duodenal mucosal permeability by a mechanism involving 5-hydroxytryptamine.Submucosal mast cells in the gastrointestinal tract are a target of staphylococcal enterotoxin type A.Suppression of Cisplatin-Induced Vomiting by Cannabis sativa in Pigeons: Neurochemical Evidences.
P2860
Q24681066-DC603A6D-FB5D-4AEB-8E52-161013B0B7C3Q28541938-4AAE749A-A419-4A26-AD92-91928406B0BCQ30436557-608F31B2-ABC6-46D0-907A-837717CB4A78Q33638271-0D7BCA5D-3755-4429-A414-2AE6479E66C3Q33967946-5D845ED7-40F7-44C2-A44C-449D76012B41Q33992722-0C76B0DD-6813-4A9D-A202-38F5A4A86806Q34509740-129B3238-E46C-42B4-9449-7BF24247F6DBQ34792198-52E0B912-1072-41AC-9DF9-592202CE2CD6Q34807270-23DBB0E7-BF8F-48CB-A761-E6A9F44EB993Q34993925-9B955711-7A56-45D7-8D5B-2CD58277CD5DQ35159856-5EB7034A-B5EC-4967-B5C8-E5E6ABAF9D2AQ35164623-19B1BDED-2E33-4979-A647-9654F58922D6Q36376786-ED07E107-EFA8-4F21-A0BC-88DA6ADBC471Q36478089-BB281522-0B5C-4055-A3EF-BA9DA8AC2793Q36639951-346A487C-2CD3-409F-8935-230479D8224FQ36681766-CE3A4282-454F-4814-8C44-F7ACD776C4A5Q37407809-C86A7327-77FD-4DA1-964B-5A041F7CF023Q37559641-4F41FDAC-D831-4C6B-8C55-B5C2C100D4F9Q38123245-7DF978BC-01D5-4360-BD04-984EE1C4EF48Q38132238-0193D1AC-861B-4A5F-995A-703BA9FF1FE5Q38689483-86D641C4-330F-45E1-8945-60E7E2333A87Q38722201-19B9DF8C-BB03-42A0-8CE5-DA34CF92D6F6Q38974456-CDC32878-C899-4069-93CF-2FB538A944EDQ39152497-8D30028F-AB83-4137-91A5-9BF89CF1AD47Q40978787-25756789-4F93-4176-8204-410C3B9B47DEQ42148759-73D97BB2-AEFC-4B00-B77A-CD51C7929D97Q42201240-53225DED-2D77-44E9-AC2A-F1EB2686978AQ42864944-5A907F56-7EF8-4378-B7C9-03471A54AEB6Q45159069-86AD53FC-25DD-41E7-88FA-AC037DC43433Q46270338-1830A9CA-074A-4D76-A0FC-96F18D54C1D4Q46721499-A1C34138-3722-4383-A042-27DC150F81E5Q46815780-F57309A5-A46E-4FB6-B06A-CAF736BD5BFBQ46959758-EC6EDFA8-E382-45D2-AD01-5F93B2B7D838Q50261433-8E2AAA92-1DD7-481A-A9EE-7AA24CB97AACQ55116566-28823528-BE3D-4A8C-95F6-07224FE95380
P2860
Pharmacological aspects of anticancer drug-induced emesis with emphasis on serotonin release and vagal nerve activity.
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Pharmacological aspects of ant ...... ease and vagal nerve activity.
@ast
Pharmacological aspects of ant ...... ease and vagal nerve activity.
@en
Pharmacological aspects of ant ...... ease and vagal nerve activity.
@nl
type
label
Pharmacological aspects of ant ...... ease and vagal nerve activity.
@ast
Pharmacological aspects of ant ...... ease and vagal nerve activity.
@en
Pharmacological aspects of ant ...... ease and vagal nerve activity.
@nl
prefLabel
Pharmacological aspects of ant ...... ease and vagal nerve activity.
@ast
Pharmacological aspects of ant ...... ease and vagal nerve activity.
@en
Pharmacological aspects of ant ...... ease and vagal nerve activity.
@nl
P2093
P1476
Pharmacological aspects of ant ...... ease and vagal nerve activity.
@en
P2093
Hideya Saito
Masahiko Hirafuji
Masahiro Nemoto
Masaru Minami
Mitsuhiro Yoshioka
Naoya Hamaue
Tsutomu Hiroshige
Yanxia Liu
P304
P356
10.1016/S0163-7258(03)00057-3
P577
2003-08-01T00:00:00Z